TenderDekho Logo
GEM

Procurement Opportunity: Acetazolamide Tablets (V2) in MEDAK, TELANGANA

Bid Publish Date

05-Mar-2025, 2:21 pm

Bid End Date

05-Apr-2025, 9:00 am

Latest Corrigendum Available

Progress

Issue05-Mar-2025, 2:21 pm
Corrigendum02-Apr-2025
AwardPending
Explore all 5 tabs to view complete tender details

Quantity

6000

Bid Type

Two Packet Bid

Categories 4

Bharat Heavy Electricals Limited (bhel) has released a public tender for Acetazolamide Tablets (V2) (Q2) in MEDAK, TELANGANA. Quantity: 6000. Submission Deadline: 05-04-2025 09: 00: 00. Download documents and apply online.

Documents 4

GeM-Bidding-7607818.pdf

Main Document

GeM Category Specification

GEM_CATEGORY_SPECIFICATION

Buyer uploaded ATC document

ATC

GEM General Terms and Conditions Document

GEM_GENERAL_TERMS_AND_CONDITIONS

Past Similar Tenders (Historical Results)

5 found

Acetazolamide Tablets (V2),Acyclovir Tablets (V2),Amiodarone Tablets (V2),Bicalutamide Tablets (V2)

N/A

JALANDHAR, PUNJAB

Posted: 30 June 2025
Closed: 17 July 2025
GEM

Lorazepam Tablet

Bharat Heavy Electricals Limited (bhel)

MEDAK, TELANGANA

Posted: 15 February 2025
Closed: 7 March 2025
GEM

Levetiracetam Tablet

N/a

UDUPI, KARNATAKA

Posted: 18 June 2025
Closed: 28 June 2025
GEM

Government Medical College And Hospital Chandigarh Levetiracetam Tablet Tender 2025 ISO/GMP WHO GMP 2025

Government Medical College And Hospital

CHANDIGARH, CHANDIGARH

Posted: 27 October 2025
Closed: 1 December 2025
GEM

Metoprolol Tablet

Indian Space Research Organization

BANGALORE, KARNATAKA

Posted: 10 January 2025
Closed: 31 January 2025
GEM

🤖 AI-Powered Bidder Prediction

Discover companies most likely to bid on this tender

Live AI
Historical Data

Corrigendum Updates

3 Updates
#1

Update

02-Apr-2025

Extended Deadline

05-Apr-2025, 9:00 am

Opening Date

05-Apr-2025, 9:30 am

#2

Update

18-Mar-2025

Extended Deadline

21-Mar-2025, 9:00 am

Opening Date

21-Mar-2025, 9:30 am

#3

Update

12-Mar-2025

Extended Deadline

15-Mar-2025, 9:00 am

Opening Date

15-Mar-2025, 9:30 am

Frequently Asked Questions

Key insights about TELANGANA tender market

What are the eligibility requirements for Acetazolamide Tablets (V2)?

The eligibility requirements for bidding include being a registered pharmaceutical company with the necessary licenses for manufacturing or supplying medicinal products. Companies must demonstrate previous experience in supplying similar items and comply with health regulations. Financial statements may need to be provided as evidence of financial capability.

What technical specifications must be met for Acetazolamide Tablets (V2)?

The technical specifications for the Acetazolamide Tablets include adherence to Good Manufacturing Practices (GMP) and compliance with applicable industry standards. The product's formulation must meet health regulations, and bidders should provide comprehensive details about the active ingredients, excipients, and packaging.

What are the EMD details required for this tender?

The Earnest Money Deposit (EMD) is typically a percentage of the bid amount and is required to ensure the commitment of the bidders. It will be refunded to unsuccessful bidders upon the completion of the tender process. Successful bidders will have their EMD adjusted against the performance security requirements.

How will submissions be evaluated for Acetazolamide Tablets (V2)?

The evaluation process entails assessing technical qualifications, pricing, and compliance with local regulations. An evaluation committee will review all submissions, and scores will be assigned according to the established criteria, identifying the most suitable supplier based on quality and cost.

What benefits exist for MSEs or startups participating in this tender?

Micro, Small, and Medium Enterprises (MSEs) and startups can benefit from specific provisions designed to support their participation in this tender. This includes possible financial concessions, simplified documentation processes, and encouragement to comply with 'Make in India' policies, aimed at fostering local manufacturing and procurement practices.